Avdeyev, four others from CBM nominated to VeroPharm board of directors
MOSCOW. Dec 18 (Interfax) - Co-owner of Credit Bank of Moscow (CBM) , Roman Avdeyev, whose company owns 52.01% of VeroPharm , has been nominated to VeroPharm's board of directors, the pharmaceutical company said in a statement.
Alexander Nikolashin, the president and chairman of the board of directors of CBM Capital, has also been nominated to join the company's board of directors, as have three other board members and vice presidents from CBM Capital: Andrey Kryukov, Aleksey Stepanyenko and Andrey Nosov. CBM capital is an asset management company created on March 1, 2013 to implement Avdeyev's long-term development strategy.
Other candidates included current members of VeroPharm's board of directors: the CEO of Pharmacy Chain 36.6 , Artyom Bektemirov; VeroPharm CEO Marina Pyenkvova; an analyst from the rating agency Expert RA, Andrey Vinkov; the CEO of the Investor Protection Association, Denis Kulikov and the CEO of LLC Dialog Artyom Stepanchikov.
There were also several current members who were not nominated: the chairman of the board of directors for 36.6, Sergey Krivosheyev; VeroPharm legal advisor Viktor Vasilyev; chairman of the auditing committee for 36.6, Vasily Rudomino and a member of 36.6's committee for strategic development, Arkady Gibov.
VeroPharm shareholders will elect new members to the board of directors at an extraordinary shareholders meeting on January 10.